Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,426 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer.
Iaffaioli RV, Formato R, Tortoriello A, Del Prete S, Caraglia M, Pappagallo G, Pisano A, Gebbia V, Fanelli F, Ianniello G, Cigolari S, Pizza C, Marano O, Pezzella G, Pedicini T, Febbraro A, Incoronato P, Manzione L, Ferrari E, Marzano N, Quattrin S, Pisconti S, Nasti G, Giotta G, Colucci G; Southern Italy Oncology Group. Iaffaioli RV, et al. Among authors: ferrari e. Br J Cancer. 2005 May 9;92(9):1621-5. doi: 10.1038/sj.bjc.6602579. Br J Cancer. 2005. PMID: 15856035 Free PMC article. Clinical Trial.
Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients: phase I ZANTE trial.
Facchini G, Caraglia M, Morabito A, Marra M, Piccirillo MC, Bochicchio AM, Striano S, Marra L, Nasti G, Ferrari E, Leopardo D, Vitale G, Gentilini D, Tortoriello A, Catalano A, Budillon A, Perrone F, Iaffaioli RV. Facchini G, et al. Among authors: ferrari e. Cancer Biol Ther. 2010 Sep 15;10(6):543-8. doi: 10.4161/cbt.10.6.12611. Epub 2010 Sep 8. Cancer Biol Ther. 2010. PMID: 20657175 Free article. Clinical Trial.
Second-line intra-arterial chemotherapy in advanced pancreatic adenocarcinoma.
Barletta E, Fiore F, Daniele B, Ottaiano A, D'Angelo R, Ferrari E, Formato R, Tortoriello A, Turitto G, Bruni GS, Pignata S, Iaffaioli RV. Barletta E, et al. Among authors: ferrari e. Front Biosci. 2006 Jan 1;11:782-7. doi: 10.2741/1836. Front Biosci. 2006. PMID: 16146770 Clinical Trial.
New emerging drugs in soft tissue sarcoma.
Milano A, Apice G, Ferrari E, Fazioli F, de Rosa V, de Luna AS, Iaffaioli RV, Caponigro F. Milano A, et al. Among authors: ferrari e. Crit Rev Oncol Hematol. 2006 Jul;59(1):74-84. doi: 10.1016/j.critrevonc.2005.12.002. Epub 2006 Mar 13. Crit Rev Oncol Hematol. 2006. PMID: 16533604 Review.
Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix.
Pignata S, Silvestro G, Ferrari E, Selvaggi L, Perrone F, Maffeo A, Frezza P, Di Vagno G, Casella G, Ricchi P, Cormio G, Gallo C, Iodice F, Romeo F, Fiorentino R, Fortuna G, Tramontana S. Pignata S, et al. Among authors: ferrari e. J Clin Oncol. 1999 Mar;17(3):756-60. doi: 10.1200/JCO.1999.17.3.756. J Clin Oncol. 1999. PMID: 10071263 Clinical Trial.
High-dose epirubicin, preceded by dexrazoxane, given in combination with paclitaxel plus filgrastim provides an effective mobilizing regimen to support three courses of high-dose dense chemotherapy in patients with high-risk stage II-IIIA breast cancer.
De Giorgi U, Rosti G, Zaniboni A, Ballardini M, Minzi MR, Baioni M, Ferrari E, Zornetta L, Marangolo M. De Giorgi U, et al. Among authors: ferrari e. Bone Marrow Transplant. 2003 Aug;32(3):251-5. doi: 10.1038/sj.bmt.1704125. Bone Marrow Transplant. 2003. PMID: 12858195 Clinical Trial.
1,426 results